Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | VP, GM-Infusion Capital | August 13, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date August 13, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,062 |
Reported balance
After 2026-08-13 transaction · row 1
1 source rowRow 1 · 2026-08-13 · Sale · Disposed 5,417 · Balance 17,062 F1: All shares sold were sold at the exact price disclosed. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares sold were sold at the exact price disclosed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 8, 2023 22:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-23-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 2, 2023 19:57 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,731 | $200.00 | $346,200.00 |
DisclosureSEC source: 0001698998-23-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,152 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2022. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · derivative · entry 9 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,040 Underlying: Common Stock · 2,020 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,883 Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 2,897 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · derivative · entry 7 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,897 Underlying: Common Stock · 2,897 shares Expires 2025-03-07 F2 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · derivative · entry 10 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,417 Underlying: Common Stock · 1,418 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F9 · derivative.exercise_date: These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · derivative · entry 8 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · derivative.exercise_date: These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,757 F2 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 639 | $242.93 | $155,232.27 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,967 Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-22-000001 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · derivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Underlying: Common Stock · 1,418 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F4 · derivative.exercise_date: These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · derivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,162 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,372 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 804 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000002 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 804 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs had a February 15 vest date subject to approval by the Compensation Committee, which occurred on February 18. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 377 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000002 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 243 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000007 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 243 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000007 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,140 Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 15:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000007 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:34 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000006 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,888 Underlying: Common Stock · 1,443 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 100% of the target award amount. F4 · derivative.exercise_date: These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:34 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000006 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,004 Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:34 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000006 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 805 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · derivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804 Underlying: Common Stock · 805 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F6 · derivative.exercise_date: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 805 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,282 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · derivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,282 shares Expires 2020-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 23:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000005 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,469 Read SEC document |
| January 21, 2020 Filed Jan 21, 2020 19:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 999 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000003 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,479 Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 19:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 727 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000003 · edgardoc.xml · derivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,181 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F4 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F1 · derivative.exercise_date: These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 19:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 242 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000004 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 Underlying: Common Stock · 242 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 242 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000004 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 108 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,055 Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 805 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · derivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609 Underlying: Common Stock · 805 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: These Securities are Performance Stock Units. F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the performance stock units. F6 · derivative.exercise_date: These performance stock units were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These performance stock units vest on February 15 of the first, second, and third year following the year of grant. Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,163 Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 805 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,282 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · derivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,282 Underlying: Common Stock · 2,282 shares Expires 2020-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 13, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594 Read SEC document |
| February 13, 2019 Filed Feb 22, 2019 17:27 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-19-000002 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2018 Filed May 24, 2018 22:44 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,763 | $273.67 | $482,479.68 |
DisclosureSEC source: 0001698998-18-000004 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $273.65 to $273.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 27, 2017 Filed Jan 21, 2020 19:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantPerformance Shares · Derivative | 727 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-20-000003 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727 Underlying: Common Stock · 727 shares Expires 2019-12-31 F1 · derivative.exercise_date: These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.